Washington: Blood clots that kill hundreds of people worldwide each year after joint replacement surgery could be stopped without needles, says a new study.Blood clots, known as deep-vein thrombosis, affect the large veins in the lower leg and thigh. If the clot breaks free and moves through the bloodstream, it can lodge in lungs, a condition known as pulmonary embolism which is often fatal.
"We now have a better treatment that reduces the risk of bleeding, and a patient no longer has to endure injections by needle," team leader Gary Raskob of University of Oklahoma said. According to the researchers, as the population ages, the number of hip and knee replacements will skyrocket in the coming years, so an easier to use and safe preventive medicine is essential. Apixaban is now being studied in Phase III clinical trials and if approved by the US Food and Drug Administration, it will be an important option for patients having the joint replacement surgery. Bureau Report
Tejas closer to induction into IAF
No plans to drop charges against Khobragade: US
`Dhoom 3` audience verdict
Lieutenant Governor Najeeb Jung recommends President`s rule in Delhi